Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v9-FR
Language English French
Date Updated 2024-07-31 2024-07-30
Drug Identification Number 02245571 02245571
Brand name BACIJECT BACIJECT
Common or Proper name BACITRACIN FOR INJECTION USP BACITRACIN FOR INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients BACITRACIN BACITRACIN
Strength(s) 50000UNIT 50000UNIT
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration TOPICAL INTRAMUSCULAR TOPICAL INTRAMUSCULAR TOPICAL INTRAMUSCULAR TOPICAL INTRAMUSCULAR
Packaging size 10 VIALS 10 VIALS
ATC code J01XX J01XX
ATC description OTHER ANTIBACTERIALS OTHER ANTIBACTERIALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2024-06-24 2024-06-24
Estimated end date 2024-07-30 2024-07-30
Actual end date 2024-07-30 2024-07-30
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Delay in releasing the product. Delay in releasing the product.
Health Canada comments